restriction. Zero-Lithium means zero-hassle at thecheck-in.
Certain airlines have refused to let Li-Ion ENGbatteries on-board aircraft in hand luggage, despite
In addition to the air transportation benefits, the PAG
legitimate safety certification that proves compliance
ZL-150 is an economical solution for those who require
with IATA regulations for lithium content and United
a high-capacity battery with extended run-time, and a
Nations testing. For this reason, PAG has introduced
higher current-draw capability, compatible with either
the ZL-Series of Travel Pack batteries that contain
zero-lithium, and are always welcome aboard.
The ZL-50 is more compact and lighter-in-weight than
The ZL-Series comprises battery packs with
the 150 watt-hour pack. It has a capacity of approx-
capacities of approximately 50 watt-hours and
imately 50 watt-hours and is also available in V-Mount
150 watt-hours that are compatible with either the
and PAGlok formats. It features a four-LED sate-of-
V-Mount or PAGlok formats, as well as a 40 watt-
The NP1 format ZL-NP, has a capacity of approximately
40 watt-hours and also features a four-LED state-of-charge indicator.
The ZL-150 is PAG’s highest capacity battery, and ispackaged in PAG’s popular, slimline, SuperPack format,
ZL-Series batteries are compatible with PAG All-
rather than the cumbersome ‘brick’. Li-Ion batteries
Chemistry AR Series and new V-Series chargers, which
having this capacity are limited to two units in your
PAG recommends for extending battery life.
hand luggage, whereas the ZL-150 has no such
Specifications: PAG ZL-150 PAG ZL-50 PAG ZL-NP Model 9316 (PAGlok Connector). Model 9315 (PAGlok Connector). Model No. 9314 Model 9316V (V-Mount Connector). Model 9315V (V-Mount Connector). Construction: ZL-NP batteries have welded cell interconnections of low-resistance Construction: PAG ZL-150 batteries have Construction: ZL-50 batteries have welded
cell interconnections of low-resistance nickel
consists of high-impact injection mouldings
resistance nickel strap. The case for these
strap. The case for these models consists of
designed to protect the cells from impact
mouldings with an internal cradle feature
internal cradle feature designed to protect the
designed to protect the cells from impact
cells from impact damage. The batteries are
Cells: Premium grade Nickel-Metal Hydride
sealed rechargeable cylindrical cells. Cells: Premium grade Nickel-Metal Hydride Cells: Premium grade Nickel-Metal Hydride
sealed rechargeable cylindrical cells. Voltage: 13.2V nominal (11 cells connected
sealed rechargeable cylindrical cells.
in series, nominal voltage 1.2V per cell). Voltage: 14.4V nominal (12 cells connected Voltage: 14.4V Nominal (12 cells connected
in series, nominal voltage 1.2V per cell). Capacity: 3 Ampere-hours nominal.
in series, nominal voltage 1.2V per cell). Capacity: 3.2 Ampere-hours nominal. Output Current: Rated maximum output Capacity: 10 Ampere-hours nominal. State of Charge Indication: An LED-array Output Protection: The ZL-150 battery is State of Charge Indication: An LED-array Output Protection: The ZL-50 battery is
resetting protection device. Rated maximum
protected against short circuit and excessive
Output Protection: The PAG ZL-NP battery
continuous output current is 10 amperes.
continuous output current is 7 Amperes.
resetting protection device. The battery is
The battery is also protected against over-
also protected against over-temperature by
means of a non-resetting thermal fuse rated
Operating Temperature Range: Optimum
discharge efficiency is achieved within thetemperature range 0°C to +40°C. Operating Temperature Range: Optimum Operating Temperature Range: Optimum
discharge efficiency is achieved within the
discharge efficiency is achieved within the
Weight: 2.35kg (5.2lb) approx. Size (H x W x D): Weight: 880g (2lb approx.) Weight: 730g (1.6lb approx.)
PAGlok Model 9316208 x 125 x 44mm (excluding claws). Size (H x W x D): Size (H x W x D): 182 x 71 x 25mm.
2007 PAG Ltd. PAG is the trademark of PAG Ltd.
ORIGINAL RESEARCH A Comparison of Moxifloxacin and Azithromycin in the Treatment of Acute Exacerbations of Chronic Bronchitis Siegfried R. Kreis, MD, MSEd, Nilo Herrera, MD, Nasim Golzar, MD, H.D. Fuller, MD, Allen Heyd, PhD, and the Therapeutic Circles Bronchitis Study Group • Objective: To compare the efficacy, safety, and patient-reported effectiveness of short-course moxifloxac
FARMAKOLOGISK BEHANDLING VID LÅNGVARIG OCH ÅTERKOMMANDE SMÄRTA AV ICKE MALIGN ORSAK HOS BARN Dokumentet är framtaget av: Mats Karling, överläkare, medicine doktor, Norrlands Universitetssjukhus, Umeå Eva Kokinsky, överläkare, medicine doktor, Drottning Silvias barn- och ungdomssjukhus, Göteborg Smärta i samband med långvarig sjukdom som t.ex. cancer och reumatiska sjukdomar kräv